Hormone Replacement Therapy And Breast Cancer
by: Patricia T. Kelly, Ph. D.
You have permission to publish this article electronically or in print, free of charge, as long as the byline is included. A courtesy copy of your publication would be appreciated.
HORMONE REPLACEMENT THERAPY AND BREAST CANCER: THE RISKS IN PERSPECTIVE
Janet M., a fifties-something woman, entered my office and said as she sat down, "I've read that if I take hormones I'll increase my breast cancer risk. I'm going crazy without sleep and with these mood swings, but I don't want to increase my breast cancer risk by taking hormones."
Like many women, Janet had heard that a recent study, the Women's Health Initiative (WHI), definitively showed that hormone replacement therapy (HRT) increases breast cancer risk. Janet, like most people, didn't realize that this study found no statistically significant increase in breast cancer risk to women who took HRT.
When differences are not significant, an increase in risk may well be due to other factors, not the one being studied, such as HRT use. As often happens when a medical story is reported, the emphasis was on the increase in risk, not whether the increase was likely to be due to the agent being studied or to the size of the risk.
The actual size of a risk is important in any woman's decision making process. In this case the risk was exceedingly small -- only 8 in 10,000 women a year -- which is 0.08% or eight hundredths of one percent! Janet was amazed to learn the actual size of the increase, and said, "You mean I was getting all concerned for a risk that small!"
"And," I pointed out, "even this very small difference in risk may not be due to hormone use." I explained that breast cancers take an average of eight years to reach about half an inch in size. This means that breast cancers started in the first year of the study would not be detected for eight or more years. The study followed women for only about five years, so all or most of the breast cancers found were probably present in an undetected state before the study began.
Janet asked if HRT use might have caused some breast cancers to grow more rapidly and therefore be detected sooner than eight years. This is unlikely. A number of studies find that breast cancers in women who were using HRT were not larger and were not dividing more rapidly than breast cancers in non hormone users. Since breast cancers grow more slowly in older women and the average age in this study was 63, breast cancers in this group would tend to grow more slowly and so take even longer than the eight year average to be detected.
Women in the WHI study used a particular type of hormone Prempro. The results of this study therefore do not apply to other, newer approaches in which more natural hormones are used and a woman's menstrual cycle is more closely approximated.
Janet was surprised to learn that many studies find that women who use HRT do not have an increase in breast cancer risk compared to women who don't use hormones, even when hormones are used for twenty years. Also, in another large study in which some women were assigned to take Prempro and others not, women who used Prempro had no significant increase in breast cancer risk.
As Janet left, she said, "I can see now that when I hear about a study I need to know how big a risk is and not just that it is increased. I'll also ask how long a study it was. This discussion has given me a whole different perspective."
Understand and manage your cancer risk. Visit http://www.ptkelly.com and sign up for our free teleforum.
Patricia T. Kelly, Ph.D. is a medical geneticist who specializes in providing information about cancer risk to individuals and health professionals. She is affiliated with Saint Francis Memorial Hospital in San Francisco. Information about her book, Assess Your True Risk of Breast Cancer, can be found on her web site: http://www.ptkelly.com.
Dr. Kelly is a medical geneticist who has been a Diplomate of the American Board of Medical Genetics since 1982. In 1993 she became a Founding Fellow of the American College of Medical Genetics. She received her Ph.D. in genetics from the University of California, Berkeley
Friday, February 22, 2008
Tuesday, February 5, 2008
Hormone Replacement Therapy
Hormone Replacement Therapy: Breast Cancer Risk In Perspecti
by: Patricia Kelly
Many women have concluded that recent study results show that hormone replacement therapy increases breast cancer risk. A closer look at this study shows that the increase in risk was far less than half a per cent a year and may not be due to hormone
Janet M., a fifties-something woman, entered my office and said as she sat down, "I've read that if I take hormones I'll increase my breast cancer risk. I'm going crazy without sleep and with these mood swings, but I don't want to increase my breast cancer risk by taking hormones."
Like many women, Janet heard that a recent study, the Women's Health Initiative (WHI), definitively showed that hormone replacement therapy (HRT) at menopause increases breast cancer risk. Janet, like most people who heard about this study, didn't realize that the WHI study found no statistically significant increase in breast cancer risk to women who took HRT.
When differences are not significant, an increase in risk may well be due to other factors, not the one being studied, such as HRT use. In this, as in the reporting of many studies, the emphasis was on the increase in risk, not whether it was likely to be due to the agent being studied or to its size.
In addition to statistical significance, the actual size of a risk is important in any woman's decision making process. In this case the risk was exceedingly small - only 8 in 10,000 women a year - which is 0.08% or eight hundredths of one per cent! Janet was amazed to learn the actual size of the increase, and said, "You mean I was getting all concerned for a risk that small!"
"And," I pointed out, "even this very small difference in risk may not be due to hormone use." I explained that breast cancers take an average of eight years to reach about half an inch in size. This means that breast cancers starting in the first year of the study would not be detected for eight or more years. The study followed women for only about five years, so all or most of the breast cancers found during the study were probably present in an undetected state before the study began.
Janet asked if HRT use might have caused some breast cancers to grow more rapidly and therefore be detected sooner than eight years. This is unlikely. A number of studies find that breast cancers in women who were using HRT were not larger and were not dividing more rapidly than breast cancers in non hormone users. Also, breast cancers grow more slowly in older women. The average age in this study was 63, so breast cancers in this group would tend to grow more slowly and so take even longer than the eight year average to be detected.
Women in the WHI study used a particular type of hormone called Prempro. The results of this study therefore do not apply to other, newer approaches in which more natural hormones are used and a woman's menstrual cycle is more closely approximated.
Janet was surprised to learn that in many studies women who use HRT do not have an increase in breast cancer risk compared to women who don't use hormones, even when hormones are used for twenty years. Also, in another large study in which some women were assigned to take Prempro and others not, women who used Prempro had no significant increase in breast cancer risk.
As Janet left, she said, "I can see now that when I hear about a study I need to know how big a risk is, and not just that it is increased. I'll also ask how long a study it was. This discussion has given me a whole different perspective."
To learn more about commonsense tools for assessing breast and other cancer risks, attend a free telephone conference on Wednesday, January 22nd at 5:00 p.m. Pacific Time, 6:00 p.m. Mountain Time, 7:00 p.m. Central Time and 8:00 p.m. Eastern Time. To register for this unique TeleForum or to learn more about it, send an E-mail to health@coachnet.com with "Cancer Risk TeleForum" in the subject line. Please include your name, E-mail address, and city and state in the body of the E-mail. Occupation or profession is optional, but it would be helpful to us. We will send a confirmation, including the number to call for this unique, free telephone conference.
You may also be interested in Dr. Kelly's latest book, Assess Your True Risk of Breast Cancer. To learn more about this book, which helps women to manage their breast cancer risk and make decisions about genetic testing, see Dr. Kelly's website: www.ptkelly.com.
About the Author
Patricia T. Kelly, Ph.D. is a medical geneticist who has provided Cancer Risk Assessment for over twenty years. She specializes in helping individuals and physicians make sense of the often conflicting information. Her most recent book, Assess Your True Risk of Breast Cancer, focuses on understanding and managing this risk.
by: Patricia Kelly
Many women have concluded that recent study results show that hormone replacement therapy increases breast cancer risk. A closer look at this study shows that the increase in risk was far less than half a per cent a year and may not be due to hormone
Janet M., a fifties-something woman, entered my office and said as she sat down, "I've read that if I take hormones I'll increase my breast cancer risk. I'm going crazy without sleep and with these mood swings, but I don't want to increase my breast cancer risk by taking hormones."
Like many women, Janet heard that a recent study, the Women's Health Initiative (WHI), definitively showed that hormone replacement therapy (HRT) at menopause increases breast cancer risk. Janet, like most people who heard about this study, didn't realize that the WHI study found no statistically significant increase in breast cancer risk to women who took HRT.
When differences are not significant, an increase in risk may well be due to other factors, not the one being studied, such as HRT use. In this, as in the reporting of many studies, the emphasis was on the increase in risk, not whether it was likely to be due to the agent being studied or to its size.
In addition to statistical significance, the actual size of a risk is important in any woman's decision making process. In this case the risk was exceedingly small - only 8 in 10,000 women a year - which is 0.08% or eight hundredths of one per cent! Janet was amazed to learn the actual size of the increase, and said, "You mean I was getting all concerned for a risk that small!"
"And," I pointed out, "even this very small difference in risk may not be due to hormone use." I explained that breast cancers take an average of eight years to reach about half an inch in size. This means that breast cancers starting in the first year of the study would not be detected for eight or more years. The study followed women for only about five years, so all or most of the breast cancers found during the study were probably present in an undetected state before the study began.
Janet asked if HRT use might have caused some breast cancers to grow more rapidly and therefore be detected sooner than eight years. This is unlikely. A number of studies find that breast cancers in women who were using HRT were not larger and were not dividing more rapidly than breast cancers in non hormone users. Also, breast cancers grow more slowly in older women. The average age in this study was 63, so breast cancers in this group would tend to grow more slowly and so take even longer than the eight year average to be detected.
Women in the WHI study used a particular type of hormone called Prempro. The results of this study therefore do not apply to other, newer approaches in which more natural hormones are used and a woman's menstrual cycle is more closely approximated.
Janet was surprised to learn that in many studies women who use HRT do not have an increase in breast cancer risk compared to women who don't use hormones, even when hormones are used for twenty years. Also, in another large study in which some women were assigned to take Prempro and others not, women who used Prempro had no significant increase in breast cancer risk.
As Janet left, she said, "I can see now that when I hear about a study I need to know how big a risk is, and not just that it is increased. I'll also ask how long a study it was. This discussion has given me a whole different perspective."
To learn more about commonsense tools for assessing breast and other cancer risks, attend a free telephone conference on Wednesday, January 22nd at 5:00 p.m. Pacific Time, 6:00 p.m. Mountain Time, 7:00 p.m. Central Time and 8:00 p.m. Eastern Time. To register for this unique TeleForum or to learn more about it, send an E-mail to health@coachnet.com with "Cancer Risk TeleForum" in the subject line. Please include your name, E-mail address, and city and state in the body of the E-mail. Occupation or profession is optional, but it would be helpful to us. We will send a confirmation, including the number to call for this unique, free telephone conference.
You may also be interested in Dr. Kelly's latest book, Assess Your True Risk of Breast Cancer. To learn more about this book, which helps women to manage their breast cancer risk and make decisions about genetic testing, see Dr. Kelly's website: www.ptkelly.com.
About the Author
Patricia T. Kelly, Ph.D. is a medical geneticist who has provided Cancer Risk Assessment for over twenty years. She specializes in helping individuals and physicians make sense of the often conflicting information. Her most recent book, Assess Your True Risk of Breast Cancer, focuses on understanding and managing this risk.
Subscribe to:
Posts (Atom)
